1.30

1.56% 0.02

Heron Therapeutics Inc (HRTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HRTX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.28

Offen:

$1.29

24-Stunden-Volumen:

524.31K

Relative Volume:

0.31

Marktkapitalisierung:

$238.31M

Einnahmen:

$137.74M

Nettoeinkommen (Verlust:

$-27.97M

KGV:

-8.125

EPS:

-0.16

Netto-Cashflow:

$-9.61M

1W Leistung:

-2.99%

1M Leistung:

+3.17%

6M Leistung:

-31.94%

1J Leistung:

-29.35%

1-Tages-Spanne:

$1.285

$1.33

1-Wochen-Bereich:

$1.275

$1.385

52-Wochen-Spanne:

$1.04

$2.68

Heron Therapeutics Inc Stock (HRTX) Company Profile

Firmenname

Heron Therapeutics Inc

Sektor

Healthcare (1146)

Branche

Biotechnology (637)

Telefon

(858) 251-4400

Adresse

4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA

Mitarbeiter

122

Twitter

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

HRTX's Discussions on Twitter

Vergleichen Sie HRTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HRTX Heron Therapeutics Inc	1.30	234.64M	137.74M	-27.97M	-9.61M	-0.16
VRTX Vertex Pharmaceuticals Inc	408.60	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	472.79	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	561.54	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	801.70	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	331.41	35.16B	4.56B	-176.77M	225.30M	-1.7177

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-09	Eingeleitet	H.C. Wainwright	Buy
2024-06-13	Eingeleitet	Rodman & Renshaw	Buy
2024-04-23	Eingeleitet	CapitalOne	Overweight
2024-03-13	Bestätigt	Needham	Buy
2020-05-27	Eingeleitet	Guggenheim	Buy
2020-02-20	Bestätigt	Needham	Buy
2019-01-16	Bestätigt	Needham	Buy
2018-04-05	Eingeleitet	Evercore ISI	Outperform
2018-03-19	Bestätigt	Mizuho	Buy
2018-03-01	Bestätigt	Needham	Buy
2018-01-03	Eingeleitet	Leerink Partners	Outperform
2017-09-27	Eingeleitet	Northland Capital	Outperform
2017-02-27	Eingeleitet	Needham	Buy
2016-10-26	Eingeleitet	Aegis Capital	Buy
2016-09-06	Fortgesetzt	Lake Street	Buy
2016-05-03	Eingeleitet	Cantor Fitzgerald	Buy
2015-12-10	Eingeleitet	Lake Street	Buy
2015-09-23	Bestätigt	Leerink Partners	Outperform
2015-09-02	Eingeleitet	BofA/Merrill	Buy
2015-08-03	Bestätigt	Brean Capital	Buy
2015-06-30	Bestätigt	JMP Securities	Mkt Outperform
2015-06-19	Bestätigt	Leerink Partners	Outperform
2014-08-07	Eingeleitet	Noble Financial	Buy

Alle ansehen

Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten

10:52 AM

Building trade automation scripts for Heron Therapeutics Inc.2025 Technical Overview & Verified Trade Idea Suggestions - newser.com

10:52 AM

10:46 AM

Published on: 2025-10-13 09:46:10 - newser.com

10:46 AM

09:21 AM

Why Heron Therapeutics Inc. stock could benefit from AI revolutionQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com

09:21 AM

09:05 AM

Can Heron Therapeutics Inc. stock weather global recessionMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com

09:05 AM

01:41 AM

Heron Therapeutics Inc. stock prediction for this weekQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com

01:41 AM

Oct 12, 2025

Cyndeo Wealth Partners LLC Takes Position in Heron Therapeutics, Inc. $HRTX - MarketBeat

Oct 12, 2025

Is Heron Therapeutics Inc AXD2 a good long term investment - earlytimes.in

Oct 12, 2025

Oct 11, 2025

Heron Therapeutics (NASDAQ:HRTX) Upgraded at Zacks Research - Defense World

Oct 11, 2025

Oct 10, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by Zacks Research - MarketBeat

Oct 10, 2025

Chart based analysis of Heron Therapeutics Inc. trendsBear Alert & Momentum Based Trading Signals - newser.com

Oct 10, 2025

Oct 09, 2025

How Heron Therapeutics Inc. (AXD2) stock reacts to stronger dollarMarket Sentiment Report & Real-Time Buy Signal Notifications - newser.com

Oct 09, 2025

Heron Therapeutics (NASDAQ:HRTX) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 06, 2025

Why Heron Therapeutics Inc. is moving today2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Heron Therapeutics Inc. stock retracement – recovery analysisTrade Exit Summary & Entry Point Confirmation Alerts - newser.com

Oct 05, 2025

Is Heron Therapeutics Inc. stock positioned well for digital economyShort Setup & Smart Money Movement Alerts - newser.com

Oct 05, 2025

Why Heron Therapeutics Inc. stock remains on buy lists2025 AllTime Highs & Verified Short-Term Plans - newser.com

Oct 05, 2025

What data driven models say about Heron Therapeutics Inc.’s future - newser.com

Oct 05, 2025

Oct 03, 2025

Why Heron Therapeutics Inc. (AXD2) stock could be top winnerChart Signals & Smart Money Movement Tracker - newser.com

Oct 03, 2025

Oct 01, 2025

Published on: 2025-10-01 09:34:43 - newser.com

Oct 01, 2025

Chart overlay techniques for tracking Heron Therapeutics Inc.Trade Analysis Summary & Reliable Price Breakout Alerts - newser.com

Oct 01, 2025

Sep 29, 2025

Why Heron Therapeutics Inc. (AXD2) stock signals breakout potentialJuly 2025 Earnings & Consistent Growth Equity Picks - newser.com

Sep 29, 2025

Sep 28, 2025

What analysts say about Heron Therapeutics Inc AXD2 stockFundamental Strength Indicators & Free Hedging Tactics for Volatile Markets - Early Times

Sep 28, 2025

Sep 27, 2025

Is Heron Therapeutics Inc a good long term investmentSector Rotation Strategies & Free Dynamic Capital Growth - Early Times

Sep 27, 2025

Sep 24, 2025

Heron Therapeutics Strengthens Financial Position with Refinancing - MSN

Sep 24, 2025